Skip Navigation

Cardiovascular Research 1997 34(2):329-336; doi:10.1016/S0008-6363(97)00042-4
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schaefer, S.
Right arrow Articles by Ramasamy, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaefer, S.
Right arrow Articles by Ramasamy, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Short-term inhibition of the Na–H exchanger limits acidosis and reduces ischemic injury in the rat heart

Saul Schaefer* and Ravichandran Ramasamy

Division of Cardiovascular Medicine, University of California Davis, TB 172, Davis, CA 95616, USA

* Corresponding author. Tel. +1 (916) 752-0717; fax: +1 (916) 752-3264.

Introduction: Pharmacologic inhibition of the Na–H exchanger prior to and during ischemia has been shown to protect the ischemic heart by reducing Na–H exchange. However, pH regulation in the ischemic heart is primarily mediated by other pH regulatory mechanisms, such as metabolite efflux and sodium-coupled HCO3 influx, which may compensate for a reduction in Na–H exchange by increasing proton efflux. We hypothesized that short-term pharmacologic inhibition of the Na–H exchanger would result in increases in other compensatory pH regulatory mechanisms and thereby limit acidosis during ischemia and reduce ischemic injury. Methods: In order to test this hypothesis, we exposed isolated perfused rat hearts to ethylisopropylamiloride (EIPA, 3 µM) for 40 min, followed by 10 min of EIPA-free perfusate and 30 min of global ischemia (termed CTL/EIPA hearts). The effects of this intervention were compared to hearts perfused with either glucose alone (CTL) or EIPA 3 µM for 10 min before ischemia (EIPA). Ischemic injury was measured using creatine kinase (CK) release on reperfusion, while pH and metabolic effects were measured using 31P nuclear magnetic resonance spectroscopy. The effect of this intervention on recovery from an acid load was assessed using an NH4Cl pre-pulse in bicarbonate-containing Krebs-Henseleit as well as HEPES buffer. Results: Both CTL/EIPA and EIPA hearts had marked reduction in ischemic injury (CK control 1191±116 IU/g dry weight; CTL/EIPA 406±42 IU/gdw; EIPA 333±78 IU/gdw), as well as significantly reduced end-diastolic pressure on reperfusion. Intracellular pH was higher in the CTL/EIPA hearts (end-ischemic pH = 6.34±0.05) compared to either control (5.86±0.02) or EIPA hearts (6.01±0.02), while pH recovery on reperfusion was markedly slowed in the CTL/EIPA hearts. CTL/EIPA hearts had rapid ATP depletion during ischemia, but PCr recovery comparable to EIPA hearts. Acidification on exposure to NH4Cl was increased in the presence of HEPES, but pH recovery was not altered by short-term exposure to EIPA. Conclusions: These data show that short-term inhibition of the Na–H exchanger altered pH regulation in the ischemic heart, resulting in reduced acidosis and slow pH recovery on reperfusion, coupled with reduction in ischemic injury and end-diastolic pressure on reperfusion. These findings are consistent with short-term exposure to EIPA accelerating ATP depletion during ischemia, as well as limiting proton efflux during reperfusion.

KEYWORDS Na+/H+ exchange; Myocardial ischemia; pH; Ethylisopropylamiloride; Rat, heart


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala
Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Spitznagel, O. Chung, Q.-G. Xia, B. Rossius, S. Illner, G. Jahnichen, S. Sandmann, A. Reinecke, M. J.A.P. Daemen, and T. Unger
Cardioprotective effects of the Na+/H+-exchange inhibitor cariporide in infarct-induced heart failure
Cardiovasc Res, April 1, 2000; 46(1): 102 - 110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. A. McLean, S. Zia, F. A. Gorin, and P. M. Cala
Cloning and expression of the Na+/H+ exchanger from Amphiuma RBCs: resemblance to mammalian NHE1
Am J Physiol Cell Physiol, May 1, 1999; 276(5): C1025 - C1037.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ramasamy, N. Trueblood, and S. Schaefer
Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H195 - H203.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.